Immunotherapy Nursing

Immunotherapy Nursing focuses on supporting patients receiving immune-based treatments such as checkpoint inhibitors, monoclonal antibodies, CAR-T cell therapy, cytokine therapies, and cancer vaccines. These treatments require specialised monitoring because they can cause unique immune-related adverse events that differ significantly from those seen with chemotherapy or radiation. This session examines how nurses prepare patients, assess early symptoms, manage escalating toxicities, and coordinate rapid interventions. At the Nursing Conference, participants will explore how immunotherapy reshapes cancer care, autoimmune treatment, and emerging infectious-disease management. Concepts from immune-modulating treatment practice provide a framework for anticipating risks, improving patient stability, and strengthening communication between multidisciplinary teams.

The session begins with an overview of how immunotherapy works. Nurses explore how drugs activate, redirect, or suppress immune responses, allowing the body to recognise and attack malignant or dysfunctional cells. Participants learn how these mechanisms can also trigger autoimmunity-like inflammation in the skin, lungs, colon, liver, endocrine glands, and nervous system. Case examples show how early detection prevents severe complications and reduces hospitalisation length.

Patient preparation and education are central themes. Nurses must explain potential side effects, expected timelines, red-flag symptoms, and self-monitoring strategies. This session reviews communication methods that enhance patient trust, reduce fear, and empower individuals undergoing complex treatment plans. Attention is given to cultural factors, literacy levels, emotional readiness, and family involvement in decision-making.

Monitoring processes are explored in depth. Participants learn how to identify immune-related toxicities such as pneumonitis, hepatitis, colitis, thyroiditis, adrenal insufficiency, neurological changes, and cytokine-release syndrome. The session emphasises documentation accuracy, frequent reassessment, and timely escalation to the medical team. Nurses review how to interpret lab trends, imaging results, and symptom patterns to guide early intervention.

Coordination of care plays a vital role. Immunotherapy often involves collaboration among oncology, immunology, endocrinology, neurology, and critical-care teams. This session discusses how nurses facilitate seamless communication, organise follow-up appointments, and support transitions between inpatient and outpatient settings. Real scenarios illustrate how proactive coordination improves survival rates and minimises treatment disruptions.

Psychosocial aspects are also highlighted. Immunotherapy can bring hope but also fear of side effects, uncertainty about response, and emotional fatigue. Nurses learn supportive-care strategies that validate feelings, encourage resilience, and address identity changes or lifestyle limitations during long-term therapy.

Finally, the session looks toward the future. Participants examine innovations such as personalised cancer vaccines, cellular therapies, biomarkers for response prediction, and digital tools for symptom tracking. By the end of this session, nurses will understand how immunotherapy nursing requires advanced assessment skills, continuous learning, and collaborative care that protects patients while maximising therapeutic benefit.